CTSD and Alzheimer disease: There were no significant differences in the scores for CTSD immunostaining in FTLD (collectively), AD and healthy controls for area CA4 of the hippocampus (H = 3.5, P = 0.170), DG (H = 0.28, P = 0.869) or Tcx (H = 0.10, P = 0.949).